Virtu KCG Holdings’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Virtu KCG Holdings’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$22K	Buy	+36,838	New	+$23.1K	﹤0.01%	2717

Other funds holding CLRBZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's CLRBZ Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q2 2017: 36,838 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2717 among its holdings.

3 funds tracked by Wall St. Rank hold CLRBZ as of Q2 2017.

Virtu KCG Holdings held 36,838 shares of Cellectar Biosciences, Inc. Series A Warrants worth $22K as of Q2 2017.
Cellectar Biosciences, Inc. Series A Warrants was a new Virtu KCG Holdings position in Q2 2017.
Cellectar Biosciences, Inc. Series A Warrants made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2717 holding.
3 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.